The Food and Drug Administration (FDA) has urged antidepressant manufacturers not to disclose to physicians and the public that some clinical trials of the medications in children found the drugs were no better than sugar pills. Regulators suppressed the negative information on the grounds that it might scare families and physicians away from the drugs.
For at least three medications, the FDA blocked the companies' plans to reveal the negative studies on drug labels, and in one case the agency reversed a manufacturer's decision to amend its drug label to say that the drug was associated in studies with increased hostility and suicidal thinking among children.
Now the The New England Journal of Medicine reports that a majority of studies that get published about antidepressants are positive because negative studies remain unpublished. Read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment